You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Methylphenidate

Showing 1 - 25 of 585
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Methylphenidate Treatment in ADHD

Not yet recruiting
  • Methylphenidate
  • Metabolomics
  • methylphenidate
  • (no location specified)
Oct 6, 2023

Alcohol Use Disorder, ADHD Trial (Methylphenidate Pill)

Not yet recruiting
  • Alcohol Use Disorder
  • Attention Deficit Hyperactivity Disorder
  • Methylphenidate Pill
  • (no location specified)
Sep 26, 2023

ADHD Trial in Baltimore (Methylphenidate, Placebo)

Not yet recruiting
  • ADHD
  • Methylphenidate
  • Placebo
  • Baltimore, Maryland
    Johns Hopkins School of Medicine
Oct 5, 2023

Substance Use Disorder, Cocaine Use Disorder Trial in New York (Methylphenidate, Memory reconsolidation, Placebo)

Recruiting
  • Substance Use Disorder
  • Cocaine Use Disorder
  • Methylphenidate
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 28, 2023

Adult ADHD, Adult-onset ADHD With Mood Disorder Trial in Strasbourg (Placebo, Methylphenidate immediate release 25mg)

Not yet recruiting
  • Adult ADHD
  • Adult-onset ADHD With Mood Disorder
  • Placebo
  • Methylphenidate immediate release 25mg
  • Strasbourg, France
    Service de Psychiatrie 2, Hôpitaux Universitaires de Strasbourg
Apr 14, 2023

Parkinson Disease, Apathy Trial (Psychosocial intervention, Methylphenidate)

Not yet recruiting
  • Parkinson Disease
  • Apathy
  • Psychosocial intervention
  • Methylphenidate
  • (no location specified)
Dec 28, 2022

Mechanism of Action of Methylphenidate in ADHD

Not yet recruiting
  • Attention Deficit Hyperactivity Disorder
  • Methylphenidate
  • (no location specified)
Oct 26, 2022

PTSD (PTSD) Trial in Tuscaloosa, Seattle (Methylphenidate, Placebo)

Not yet recruiting
  • Posttraumatic Stress Disorder (PTSD)
  • Methylphenidate
  • Placebo
  • Tuscaloosa, Alabama
  • +1 more
Mar 8, 2023

Adhd Trial (prolong-release methylphenidate)

Not yet recruiting
  • Adhd
  • prolong-release methylphenidate
  • (no location specified)
Jun 5, 2022

Attention Deficit Disorder With Hyperactivity, Diabetes, Type 1 Trial (parental training in behavior management,

Not yet recruiting
  • Attention Deficit Disorder With Hyperactivity
  • Diabetes Mellitus, Type 1
  • parental training in behavior management
  • +2 more
  • (no location specified)
Jul 19, 2023

Schizophrenia Schizoaffective Trial (Apo-Methylphenidate ER)

Recruiting
  • Schizophrenia Schizoaffective
  • Apo-Methylphenidate ER
  • Ottawa, Ontario, Canada
    Royal Ottawa Mental Health Centre
Oct 31, 2022

ADHD, ADHD Trial in Irvine (Methylphenidate Hydrochloride Extended Release Capsules, Placebo)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • ADHD
  • Methylphenidate Hydrochloride Extended Release Capsule
  • Placebo
  • Irvine, California
    University of California, Irvine/Child Development Center
Nov 16, 2022

Pain Trial in Chicago (Methylphenidate, Placebo)

Recruiting
  • Pain
  • Methylphenidate
  • Placebo
  • Chicago, Illinois
    Northwestern University
Dec 30, 2022

Healthy Volunteers Trial in Lille (Methylphenidate, Placebo, CogniPlus software)

Recruiting
  • Healthy Volunteers
  • Methylphenidate
  • +3 more
  • Lille, France
    Hôpital Roger Salengro, CHU
Aug 16, 2022

Alcohol Use Disorder Trial in Lexington (Alcohol, Placebos, Duloxetine)

Recruiting
  • Alcohol Use Disorder
  • Lexington, Kentucky
    University of Kentucky
Sep 23, 2022

ADHD - Combined Type Trial in Baltimore (Methylphenidate, Placebo)

Recruiting
  • ADHD - Combined Type
  • Methylphenidate
  • Placebo
  • Baltimore, Maryland
    Johns Hopkins School of Medicine
May 12, 2022

PTSD Trial in Haifa, Netanya (Methylphenidate, Reboxetine, Placebo)

Recruiting
  • Posttraumatic Stress Disorder
  • Methylphenidate
  • +2 more
  • Haifa, Israel
  • +1 more
Nov 20, 2022

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +2 more
  • Laboratory Biomarker Analysis
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Prostate Carcinoma Trial in Houston (behavioral, drug, other)

Recruiting
  • Prostate Carcinoma
  • Exercise Intervention
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2022

Childhood Apraxia of Speech Trial in Parkville (Methylphenidate Hydrochloride, Placebo)

Recruiting
  • Childhood Apraxia of Speech
  • Methylphenidate Hydrochloride
  • Placebo
  • Parkville, Victoria, Australia
    Murdoch Children's Research Institute
May 4, 2022

Fatigue Trial in Houston (Methylphenidate, Fatigue Evaluations)

Completed
  • Fatigue
  • Methylphenidate
  • Fatigue Evaluations
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 3, 2022

Attention Deficit/Hyperactivity Disorder Combined Type, ADHD Predominantly Inattentive Type, ADHD Predominantly Hyperactivity

Recruiting
  • Attention Deficit/Hyperactivity Disorder Combined Type
  • +3 more
  • Methylphenidate- Ritalin IR (Immediate Release)
  • Ramat-Gan, Israel
    ADHD Medical Clinic, Child and Adolescent Psychiatry Unit, Sheba
May 16, 2022

ADHD, ADHD Trial in United States (Methylphenidate)

Recruiting
  • ADHD
  • Attention Deficit Hyperactivity Disorder
  • Methylphenidate
  • Gainesville, Florida
  • +3 more
Apr 5, 2022

Normal Physiology Trial run by the NIAAA (Oral Methylphenidate followed by IV , Oral followed by IV Methylphenidate, Oral

Enrolling by invitation
  • Normal Physiology
  • Oral Methylphenidate followed by IV placebo
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Language, Methylphenidate of Undetermined Intent Trial in Nijmegen (Methylphenidate 20 Mg Oral Tablet, Placebo, Language Task)

Completed
  • Language
  • Methylphenidate of Undetermined Intent
  • Methylphenidate 20 Mg Oral Tablet
  • +8 more
  • Nijmegen, Gelderland, Netherlands
    Donders Institute for Brain, Cognition and Behaviour, Centre for
Mar 21, 2022